CureVac is developing an entirely novel class of therapies based on a fundamental new understanding of the medical potential of messenger RNA (mRNA).
CureVac aims to use this new class of therapeutics
novel mRNA vaccines and adjuvants based on long, non-coding RNAs, to transform the treatment of oncological diseases and the prophylaxis for infectious diseases.
